Finn K Hansen

61PUBLICATIONS
128CO-AUTHORS
PharmacogenomicsOrganometallic chemistryCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jul 14, 2026
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

|Apr 14, 2026
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.

Mireia Toledano-Pinedo, Alicia Porro-Pérez, Linda Schäker-Hübner

|Apr 14, 2026
Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors.

Irina Honin, Zora Novakova, Felix Feller

|Mar 19, 2026
Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors.

Linda Schäker-Hübner, Finn K Hansen

|Jan 02, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies.

Shiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun

|Dec 23, 2025
Crosstalk between NLRP3 Signaling and Histone Deacetylases in Inflammasome-Driven Diseases.

Kathrin Tan, M Mercedes Rodríguez-Fernández, Tim Keuler

Pageof 11

Frequent Collaborators

10 joint publications

Michael Gütschow

9 joint publications

Thomas Kurz

9 joint publications

Sanil Bhatia

7 joint publications

Linda Schäker-Hübner